lawmakers should revisit that idea when lepage is no longer in office next year.
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
.
.
the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes.
. however, bentley also warned that these treatments can be hazardous as they may cause bleeding which becomes more likely as the amount of svd increases.
. may 16, 2018